Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Search stocks
Godrej Agrovet Ltd

| Audited Financial Results for the Quarter and Financial Year Ended March 31, 2026

BULLISH SENTIMENT

Report Source

⬤30th Apr 26

Summary : Godrej Agrovet reports strong FY26 results, recommends dividend, and expands through acquisitions and stock grants.

Quarterly Report Analysis & Insights

Financial Disclosures

  1. Cost of materials consumed
  2. Purchases of Stock-in-Trade
  3. Changes in inventories
  4. Employee benefits expense
  5. Finance costs
  6. Depreciation and amortisation expenses
  7. Other expenses
  8. Consolidated Revenue from Operations: Rs. 10,232.68 crore (FY26) vs Rs. 9,382.77 crore (FY25).
  9. Segment Revenue: Animal Nutrition, Vegetable Oil, Crop Care, Dairy, Poultry, Others.
  10. Consolidated Net Cash from Operating Activities: Rs. 1,281.17 crore (FY26) vs Rs. 969.34 crore (FY25).
  11. Consolidated Net Cash used in Investing Activities: Rs. (150.39) crore (FY26) vs Rs. (81.53) crore (FY25).
  12. Consolidated Net Cash from Financing Activities: Rs. (868.90) crore (FY26) vs Rs. (900.84) crore (FY25).
  13. Consolidated Total Assets: Rs. 6,170.19 crore (FY26) vs Rs. 5,515.99 crore (FY25).
  14. Consolidated Total Equity: Rs. 2,163.66 crore (FY26) vs Rs. 2,602.51 crore (FY25).
  15. Both standalone and consolidated financial results are presented and audited.

Corporate Overview

  1. Impairment provision for Godrej Cattle Genetics Private Ltd.
  2. Impact of new Labour Codes on gratuity and leave encashment benefits.
  3. Formal and factual reporting of board decisions.
  4. Animal Nutrition
  5. Vegetable Oil
  6. Crop Care Business
  7. Dairy
  8. Poultry and processed food
  9. Others (Seeds, Real Estate, Windmill, Cattle Genetics)
  10. Acquisition of balance stake in Creamline Dairy Products Limited.
  11. Acquisition of Godrej Foods Limited (wholly owned subsidiary).
  12. Participation in Astec LifeSciences Limited Rights Issue.

Risk Factors

  1. Impairment provision for cattle genetics business.
  2. Potential impact from new Labour Codes.
  3. Winding up of Omnivore India Capital Trust.

Key Drivers

  1. Recommended 110% final dividend per share.
  2. Approved audited financial results for FY26.
  3. Allotted equity shares under ESGS 2018.
  4. Granted new stock options to employees.

Auditor’s Report

  1. Unmodified opinion on standalone and consolidated financial results.

Board Commentary

  1. Recommended Final Dividend of Rs. 11.00 per equity share (110%) for FY 2025-26, subject to shareholder approval.
  2. Impairment provision for Godrej Cattle Genetics Private Ltd. (Note 12).
  3. Potential financial impact from new Labour Codes (Note 11).
  4. Compliance with SEBI Listing Regulations.
  5. Assessment of impact from new Labour Codes (Note 11).
  6. Allotment of 30,973 equity shares under ESGS 2018.
  7. Grant of 50,507 stock options under ESGS 2018.
  8. Acquisition of balance 36.79% equity stake in Creamline Dairy Products Limited.
  9. Acquisition of 49% stake in Godrej Foods Limited, making it wholly owned.
  10. Participation in Astec LifeSciences Limited Rights Issue of Rs. 199.01 crores.

Corporate Governance

  1. Audit Committee
  2. Nomination and Remuneration Committee

Management Discussion & Analysis

Critical Risks

  1. Impact of new Labour Codes on employee benefits.
  2. Impairment provision for Godrej Cattle Genetics Private Ltd.
  3. Winding up of Omnivore India Capital Trust.
Godrej Agrovet Ltd (GODREJAGRO) Quarterly Report Analysis & Insights | Dhanarthi